Geneos Wealth Management Inc. Abiomed Inc Transaction History

Geneos Wealth Management Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $121,245 - $150,730	-500 Reduced 83.33%	100 $24,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $27,725 - $36,629	100 Added 20.0%	600 $198,000
Q4 2020 May 19, 2021	SELL	$251.88 - $324.2 $2,518 - $3,242	-10 Reduced 1.96%	500 $150,000
Q3 2020 Sep 07, 2021	BUY	$255.22 - $317.0 $2,552 - $3,170	10 Added 2.0%	510 $135,000
Q4 2019 Sep 07, 2021	SELL	$159.31 - $223.54 $15,931 - $22,354	-100 Reduced 16.67%	500 $84,000
Q2 2019 Sep 07, 2021	SELL	$250.96 - $284.94 $2,760 - $3,134	-11 Reduced 1.8%	600 $156,000
Q4 2018 Sep 07, 2021	BUY	$281.08 - $444.25 $3,091 - $4,886	11 Added 1.83%	611 $194,000
Q4 2017 Sep 07, 2021	BUY	$168.78 - $199.74 $16,878 - $19,974	100 Added 20.0%	600 $112,000
Q2 2017 Sep 07, 2021	SELL	N/A	-12 Reduced 2.34%	500 $71,000
Q1 2017 Sep 07, 2021	SELL	N/A	-10 Reduced 1.92%	512 $64,000
Q4 2016 Sep 07, 2021	BUY	N/A	250 Added 91.91%	522 $58,000
Q3 2016 Sep 07, 2021	BUY	N/A	22 Added 8.8%	272 $34,000
Q1 2016 Sep 07, 2021	BUY	N/A	250	250 $24,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.